Cargando…
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
PURPOSE OF REVIEW: There have been significant advances in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL) over the past two decades. However, the intention of treatment remains control of the disease and delay of progression rather than a cure which remains largely elusive....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242240/ https://www.ncbi.nlm.nih.gov/pubmed/37278884 http://dx.doi.org/10.1007/s11899-023-00700-z |